Copenhagen
Denmark
19
2026-04-23
9
2026-03-31
These are the the leading inventors for applications assigned to RIGSHOSPITALET:
RIGSHOSPITALET based in Copenhagen, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
68GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS
#2 | 2026-04-02DISRUPTION OF ASXL1 IN T CELLS TO ENHANCE IMMUNOTHERAPY
#3 | 2025-05-08IMAGE INFORMATION PROCESSING APPARATUS, IMAGE INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM
#4 | 2025-05-08IMAGE INFORMATION PROCESSING APPARATUS, IMAGE INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM
#5 | 2023-11-30MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD
#6 | 2021-08-05 ✅ Patent 12,589,171 granted on 2026-03-31177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING
#7 | 2020-09-10 ✅ Patent 11,554,261 granted on 2023-01-17System for electrical stimulation during functional MRI
#8 | 2020-09-10 ✅ Patent 12,521,454 granted on 2026-01-1368GA- AND 64CU -NODAGA-E[C(RGDYK)]2 FOR USE AS PET TRACERS IN THE IMAGING OF ANGIOGENESIS IN HUMANS
#9 | 2019-05-02UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER
#10 | 2018-11-15 ✅ Patent 12,433,916 granted on 2025-10-07STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS
#11 | 2017-10-26 ✅ Patent 10,111,969 granted on 2018-10-30uPAR targeting peptide for use in peroperative optical imaging of invasive cancer
#12 | 2012-01-26DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENS
#13 | 2011-12-01TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER
#14 | 2011-08-18 ✅ Patent 9,381,166 granted on 2016-07-05Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
#15 | 2011-02-24 ✅ Patent 8,697,384 granted on 2014-04-15YKL-40 as a general marker for non-specific disease
#16 | 2008-10-23TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER
#17 | 2007-01-25 ✅ Patent 7,807,379 granted on 2010-10-05Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
#18 | 2006-09-19 ✅ Patent 7,108,983 granted on 2006-09-19Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
#19 | 2006-07-13Method for detecting, screening and/or montoring a cancer in individual
Also check out Rigshospitalet's (Copenhagen, Denmark) applicant profile with 10 patent applications submitted.
147642 ⎘